Stéphane Piat, Chief Executive Officer ofCARMAT, adds:"It is an immense pleasure to welcome Christian Latrémouilleto our management team. His arrival marksthe completion of the structuring of our Management Committee with a view to preparing the launch of ourAeson device. Hissurgical expertise coupled with the unique experience he has acquired with CARMAT will be pivotal to the successful ramping up of our commercial launch. In his new role, Christian Latrémouillewill accompany and oversee hospitals from the training phase through to patient treatment".
About CARMAT: the world's most advanced total artificial heart project
A credible response to end-stage heart failure:CARMAT aims to eventually provide a response to a major public health issue associated with heart disease, the world's leading cause of death: chronic and acute heart failure. By pursuing the development of its total artificial heart, composed of the implantable bioprosthesis and its portable external power supply system to which it is continuously connected, CARMAT intends to overcome the well-known shortfall in heart transplants for the tens of thousands of people suffering from irreversible end-stage heart failure, the most seriously affected of the 20 million patients with this progressive disease in Europe and the United States.
Back to HCB News
